Abcam plc (ABCM) NASDAQ
$23.99 0.01 (0.04%)
Market Cap: $5.52B
As of 12/05/23 04:00 PM EST. Market closed.
Abcam plc (ABCM)
NASDAQ
$23.99
0.01 (0.04%)
Market Cap: $5.52B
As of 12/05/23 04:00 PM EST. Market closed.
Add to Portfolio
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and ... read more
COMPANY PROFILE
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Alan Thomas Hirzel BS, M.B.A., M.S.
Full Time Employees
1,760
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Alan Thomas Hirzel BS, M.B.A., M.S.
Full Time Employees
1,760
URL
Address
Discovery Drive, Cambridge, CB2 0AX.
PRICE CHART FOR ABCAM PLC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$23.99
Previous Close
$23.98
Days Range
$23.98 - $24
52 week range
$12.48 - $25.32
Volume
7,430,229
Avg. Volume (30 days)
5,816,355
Market Cap
$5.52B
Dividend Yield
-
P/E
2399
Shares Outstanding
230,151,008
Open
$23.99
Previous Close
$23.98
Days Range
$23.98 - $24
52 week range
$12.48 - $25.32
Volume
7,430,229
Avg. Volume (30 days)
5,816,355
Market Cap
$5.52B
Dividend Yield
-
P/E
2399
Shares Outstanding
230,151,008
FINANCIAL STATEMENTS FOR ABCAM PLC
LOADING...
CHANGE IN SHARES OUTSTANDING FOR ABCAM PLC
STOCK BUYBACKS FOR ABCAM PLC
Load More
Period of Report: 06/30/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
12/31/2022
0.19%
2Q
06/30/2022
0.19%
4Q
06/30/2021
1.17%
8Q
12/31/2020
1.84%
10Q
06/30/2020
1.84%
12Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ABCAM PLC
LOADING...